| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 10/30/2002 | EP1252127A1 A process for the crystallization of non-sucrose substances |
| 10/30/2002 | EP1061957B1 Manganese (ii) chelates with high relaxivity in serum |
| 10/30/2002 | EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 10/30/2002 | EP0695187B1 Inhibition, control and regression of angiogenesis with hyaluronic acid or hyaluronic acid and nsaid |
| 10/30/2002 | CN1377337A Process for phenylacetic acid derivatives |
| 10/30/2002 | CN1377259A ACE-2 inhibiting compounds and methods of use thereof |
| 10/30/2002 | CN1093530C Amino acid calcium and preparation process thereof |
| 10/29/2002 | US6472548 Process for preparing a complex of a ligand, metal and base |
| 10/29/2002 | US6472349 Pyridine-2,3-dicarboxylic acid diamides |
| 10/29/2002 | US6472011 L-carnitine agent |
| 10/29/2002 | CA2057699C Process for the production of (s)-vinyl and allenyl gaba |
| 10/24/2002 | WO2002083659A1 Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these |
| 10/24/2002 | WO2002083616A1 α-SUBSTITUTED φ-ARYLFATTY ACID DERIVATIVE |
| 10/24/2002 | WO2002055479A3 Esters of alkylcarboxy amino acids as prodrugs of modulators of the kainate receptor |
| 10/24/2002 | WO2002022626A8 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 10/24/2002 | WO2002002516A3 Inhibitors of hiv integrase |
| 10/24/2002 | US20020156295 Coordination catalyst containing ligand |
| 10/24/2002 | US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis |
| 10/24/2002 | US20020155993 Especially those derived from two alpha-amino acids independently selected from the group consisting of glutamic acid, aspartic acid, tyrosine, phenylalanine, and optical isomers thereof. |
| 10/24/2002 | US20020155588 Very large scale immobilized polymer synthesis |
| 10/24/2002 | US20020153261 Subjecting a solution of a basic amino acid salt to electrodialysis with the use of an electrodialyser equipped with ion exchange membranes, adding alkali aqueous soltuion to cause desalting and removing of couner anios |
| 10/23/2002 | EP1250311A1 Asymmetric synthesis of pregabalin |
| 10/23/2002 | EP1250302A1 Method for producing carboxylic acids by alcohol oxidation |
| 10/23/2002 | CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 10/23/2002 | CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma |
| 10/22/2002 | US6469204 Acrylates comprising several quaternary amino groups in the alcohol part, their process of manufacture and the (co) polymers obtained from these monomers |
| 10/22/2002 | US6469199 Secondary aspartic acid amide esters |
| 10/22/2002 | US6469193 Efficient synthesis of alkyl carbonates |
| 10/22/2002 | US6468562 Fluidity improver and/or anti-agglomeration agent, and a hydrophobic, moisture-proof layer is arranged on the surface of the particles; use in animal feeds, cosmetics and drugs |
| 10/22/2002 | US6468502 Paramagnetic macromolecules with higher proton relaxivity; lower dosage and increased signal intensity; detecting vascular diseases; differentiating tissue blood supply levels; distinguishing myocardial infarction from ischemia |
| 10/22/2002 | US6468487 Nitration or carboxylation catalysts |
| 10/17/2002 | WO2002066456A3 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 10/17/2002 | WO2002048164A3 Isolation of nucleic acids |
| 10/17/2002 | WO2001070664A3 Lipoxin analogs and methods for the treatment of periodontal disease |
| 10/17/2002 | US20020151722 Production method of beta-amino-alpha-hydroxycarboxylic acid |
| 10/17/2002 | US20020151566 Phosphodiesterase 4 inhibitors |
| 10/17/2002 | US20020151436 Doped with iron, noble metals or other metals for use as hydrogenation catalysts |
| 10/17/2002 | DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair |
| 10/16/2002 | EP1248869A2 High-throughput formation, identification, and analysis of diverse solid-forms |
| 10/16/2002 | EP0930292B1 Process for preparing beta-amino-alpha-hydroxy acid derivatives |
| 10/16/2002 | EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 10/16/2002 | CN1374293A Green synthesis process of betaine hydrochloride |
| 10/16/2002 | CN1374025A Application of amino acid chelated magnesium as feed additive |
| 10/16/2002 | CN1092703C Aromatic esters of polyalkyl phenoxyalkanols and fuel composition containing the same |
| 10/15/2002 | US6465694 Method for preparation of polyethylene glycol aldehyde derivatives |
| 10/15/2002 | US6465690 Process for the preparation of polyamino succinic acids and derivatives thereof |
| 10/15/2002 | US6465689 Stereoselective processes for the preparation of gabapentin analogues |
| 10/15/2002 | US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 10/15/2002 | US6465684 Process for the separation of a mixture of enantiomers |
| 10/15/2002 | US6465676 Making by reacting ethylenediamine with diethyl bromomalonate and an alkali metal ion to form the tetraalkali metal salt of the aminopolycarboxylate; biodegradable chelating agent for waste water treatment, for example |
| 10/15/2002 | US6465515 Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines |
| 10/10/2002 | WO2003084997A1 Probes, systems and methods for drug discovery |
| 10/10/2002 | US20020147362 Synthesis of 2-Hydroxymethylglutamic acid and congeners thereof |
| 10/10/2002 | US20020147360 Reacting morpholinone with formaldehyde or hydrogen cyanide |
| 10/10/2002 | US20020146787 Coenzymes useful for the synthesis of L-carnitine |
| 10/10/2002 | CA2442654A1 Probes, systems, and methods for drug discovery |
| 10/09/2002 | EP1247800A1 Use of iminodisuccinic acid salts in the production of paper |
| 10/09/2002 | EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 10/09/2002 | EP1246790A1 Substituted 1 and 2 naphthol mannich bases |
| 10/09/2002 | EP1246618A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy |
| 10/09/2002 | CN1373746A Method for reducing 2-dimethylamino-2-phenylpropion-acid ethyl ester content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester |
| 10/08/2002 | US6462229 It has been found that (.+-.)-.alpha.-difluoromethylornithine can be cleaved using the commercially obtainable (-)-o,o'-di-p-toluoyl-l-tartaric acid |
| 10/08/2002 | US6462179 Conjugation to peptides, proteins, hormones, polysaccharides, nucleic acids, haptens, drugs, ligands, toxins, halophors, and other macromolecules |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide |
| 10/03/2002 | WO2002076928A2 Alkylamine derivatives as antifouling agents |
| 10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/03/2002 | US20020143158 Purification of preferential protin from sample; provide methylated aspartate ligand complexed with a transiton metal, incubate with cell lysate, elute and recover preferential protein from column |
| 10/03/2002 | US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92 |
| 10/03/2002 | CA2783647A1 Histone deacetylase inhibitors |
| 10/03/2002 | CA2441197A1 Alkylamine derivatives as antifouling agents |
| 10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/02/2002 | EP1245558A1 Alkylamine derivates as anti-fouling agents |
| 10/02/2002 | EP1244646A1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same |
| 10/02/2002 | EP1244645A1 Stereospecific hydrolysis of optically active esters |
| 10/02/2002 | EP1244612A1 Process for preparing alkylene diamine triacetic acid |
| 10/02/2002 | EP1244611A1 Squaric acid derivatives as integrin antagonists |
| 10/02/2002 | EP1100768B1 Process for the preparation of r-(-)-carnitine |
| 10/02/2002 | EP0915832B1 Boronic compound complexing reagents and highly stable complexes |
| 10/02/2002 | EP0706521B1 Imides as tnf alpha inhibitors |
| 10/02/2002 | EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring |
| 10/02/2002 | CN1372540A Non-hydroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same |
| 10/02/2002 | CN1091649C Process for preparing carboxylic acid salts and catalysts useful in such process |
| 10/01/2002 | US6458981 Method of preparing amino acid chelates free of interfering ions comprising reacting in an aqueous solution, calcium oxide or hydroxide, an amino acid, and a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the |
| 10/01/2002 | US6458966 Dye intermediate and method |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458837 Lipophilic diesters of chelating agents |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458337 Diagnostic imaging contrast agent with improved in serum relaxivity |
| 10/01/2002 | US6458293 Polyurea coatings from dimethyl-substituted polyaspartic ester mixtures |
| 09/26/2002 | WO2002074728A1 Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine |
| 09/26/2002 | WO2002074727A1 A process for the preparation of cyclic amino acids |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137902 Method for producing crystal polymorphs and crystal polymorphs produced thereby |
| 09/26/2002 | US20020137739 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 09/26/2002 | US20020137730 Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| 09/26/2002 | US20020137096 Solid phase synthesis; photolithography |
| 09/26/2002 | CA2407681A1 Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine |